Our Team

At X-tosis, we’re a cross-functional team of scientists, operators, and advisors advancing therapies that target mitochondrial dysfunction in neurodegenerative disease.

1621950265263 (1)-removebg-preview_edite

Erin Henderson

CEO, President &

Co-Founder

Naz Bashir, Ph.D.

Board Chair

1703690471019 (2)-removebg-preview_edite

Yotam Nismblat, M.Sc.

CSO & Co-Founder

1593002070283 (1)-removebg-preview_edite

Ofer Shina

COO & Co-Founder

image-removebg-preview-removebg-preview_

Josh Pan, Ph.D.

Chief of Staff, Head of BD & Co-Founder

Varda Shoshan-Barmatz, Ph.D.

Inventor & SAB

Andrew Skibo

SAB Chair

John Abernethy, M.D.

SAB

Matt LaVoie, Ph.D.

SAB

1679314492977__1_-removebg-preview__1_-removebg-preview_edited.png

Gilead Raday

SAB

Doris Snow, Ph.D.

SAB

Russell Swerdlow, M.D.

SAB